Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversidade Federal Fluminense
About this trial
This work aims to evaluate the effects of the association of green propolis extract with royal jelly on inflammation and oxidative stress in participants with chronic kidney diseases (CKD) and Systemic arterial hypertension (SAH), in a longitudinal, randomized, double-blind, placebo-controlled clinical trial that will be carried out for 2 months.
Eligibility criteria
Qualifiers
patients in stages 3 and 5 of CKD (GFR from 15 to 59 mL/min),
patients receiving ambulatorial nutrition treatment at least 6 months
patients on regular Hemodialysis treatment for at least 6 months
patients using one to three antihypertensive drugs
Disqualifiers
autoimmune and infectious diseases,
diabetes
cancer
AIDS
Trial design
Treatments tested in this trial
- Propolis associated with Royal Jelly
- Royal Jelly
- Placebo
Treatment groups
153 Participants
are divided into 3 treatment groupsLocations
2Denise Mafra22260050, Rio de JaneiroRio de Janeiro, Brazil
Denise Mafra Rio de JaneiroRio de Janeiro, Brazil
Sponsors and collaborators
Universidade Federal Fluminense
Lead sponsor
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Collaborator
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Collaborator
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Collaborator
Source ClinicalTrials.gov